We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Johnson & Johnson subsidiary Ethicon has agreed to pay the state of Kentucky $9.9 million to resolve allegations of deceptive marketing practices for Ethicon’s pelvic mesh surgical devices.
Just a day before a jury trial was set to begin, Alcon agreed to pay $199 million to J&J Surgical Vision to settle their intellectual property rights lawsuit over J&J’s laser-assisted cataract surgery software.
The FDA highlighted the need for long-term neurodevelopmental studies by sponsors of neonatal medical products —whether a drug, biologic product or device — in a new draft guidance released Friday.
A jury in the U.S. District Court for the Central District of California has awarded cardiac devicemaker Colibri Heart Valve $106.5 million for infringement by Medtronic’s CoreValve devices of Colibri’s patents for a self-expanding valve device used to replace diseased heart valves.
The European Medicines Agency (EMA) is launching a pilot program to offer scientific advice to manufacturers of certain high-risk medical devices, to help streamline their path to market.
The Medical Device Manufacturers Association (MDMA) and AdvaMed have called for several FDA actions to streamline and simplify the agency’s Voluntary Malfunction Summary Reporting(VMSR)program.